HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

W Holloway Selected Research

Vaccines

3/2000Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


W Holloway Research Topics

Disease

1HIV Infections (HIV Infection)
03/2000
1Disease Progression
03/2000

Drug/Important Bio-Agent (IBA)

1VaxSyn HIV-1 (gp160) vaccineIBA
03/2000
1VaccinesIBA
03/2000